Neuropsychological sequelae.

2004 ◽  
pp. 183-207
Author(s):  
Seth C. Kalichman
Keyword(s):  
Neuropsychological Sequelae

Neuropsychological Sequelae of Type 1 and Type 2 Diabetes

2019 ◽  
pp. 533-548
Author(s):  
Clarissa S. Holmes ◽  
Kari L. Morgan ◽  
Priscilla Powell
Keyword(s):  
Type 2 Diabetes ◽  
Neuropsychological Sequelae

Deployment to the Iraq War and Neuropsychological Sequelae

JAMA ◽  
2006 ◽  
Vol 296 (22) ◽  
pp. 2678
Author(s):  
Patricia Boiko
Keyword(s):  
Iraq War ◽  
Neuropsychological Sequelae

scholarly journals Neuropsychological sequelae in Kleine-Levin syndrome: case report

2000 ◽  
Vol 58 (2B) ◽  
pp. 531-534 ◽  
Author(s):  
LEONARDO FONTENELLE ◽  
MAURO V. MENDLOWICZ ◽  
J. CHRISTIAN GILLIN ◽  
PAULO MATTOS ◽  
MÁRCIO VERSIANI
Keyword(s):  
Case Report ◽  
Early Intervention ◽  
Natural History ◽  
Typical Case ◽  
Social Functions ◽  
Behavioral Disturbances ◽  
Neuropsychological Sequelae ◽  
History Of ◽  
Long Term Prognosis

Kleine-Levin syndrome is characterized by periodic hypersomnia, hyperphagia, sexual disinhibitions and behavioral disturbances. The prognosis is generally benign, with normal cognitive and social functions after the episodes. We describe a typical case of Kleine-Levin syndrome associated with apparent academic decline, neuropsychological sequelae and personality alterations after the second episode of the illness. Further research in the natural history of Kleine-Levin syndrome is needed, for example, to determine whether early intervention would improve long-term prognosis.

Methylphenidate in Neuropsychological Sequelae of Radiotherapy and Chemotherapy of Childhood Brain Tumors and Leukemia

1992 ◽  
Vol 7 (4) ◽  
pp. 462-463 ◽  
Author(s):  
Robert DeLong ◽  
Henry Friedman ◽  
Nancy Friedman ◽  
Kathryn Gustafson ◽  
Jerry Oakes
Keyword(s):  
Brain Tumors ◽  
Childhood Brain Tumors ◽  
Neuropsychological Sequelae

scholarly journals The Diagnosis and Treatment of Craniopharyngioma

2019 ◽  
Vol 110 (9-10) ◽  
pp. 753-766
Author(s):  
Hermann L. Müller
Keyword(s):  
Histological Grade ◽  
Clinical Manifestations ◽  
Treatment Strategies ◽  
High Standard ◽  
Proton Beam Therapy ◽  
Braf V600e ◽  
Treatment Quality ◽  
Multidisciplinary Teams ◽  
Centers Of Excellence ◽  
Neuropsychological Sequelae

Craniopharyngioma (CP) is a rare embryonic malformation of the sellar/parasellar region with a low histological grade. Clinical manifestations are related to hypothalamic/pituitary deficiencies, visual impairment, and increased intracranial pressure. Recent insight into the molecular pathogenesis of CP opens new perspectives on targeted therapy in papillary CP harboring BRAF-V600E mutations. Further research to elucidate pathogenic mechanisms and hopefully prevent hypothalamic involvement of CP is warranted. If the tumor is favorably localized, the therapy of choice is complete resection, with care taken to preserve the optical and hypothalamic functions. In patients with unfavorable tumor localization (i.e., hypothalamic involvement), the recommended therapy is a limited hypothalamus-sparing surgical strategy followed by local irradiation. Surgical treatment strategies should be based on a multidisciplinary approach involving experienced teams. Centralizing the treatment of CP in experienced “centers of excellence” and multicenter-based networks for reference assessments should be considered to assure a high standard of treatment quality. CP recurrence and progression are frequent. Irradiation has proven effective in reducing recurrences and progression. Proton beam therapy, available in a wider range in the near future, will help to avoid radio-oncological side effects. Anatomical involvement and/or surgical lesions of posterior hypothalamic areas can result in serious sequelae that compromise quality of life (QoL), such as hypothalamic obesity and psychopathological symptoms. Novel insights into neuropsychological sequelae after CP occurrence should be the basis for the development of therapeutic neuropsychological interventions. CP should be managed as a frequently chronic disease, providing ongoing care of pediatric and adult patients’ clinical and QoL consequences by experienced multidisciplinary teams.

Sign in / Sign up

Export Citation Format

Share Document